The user shared progress pictures showing improvement in hair loss using oral finasteride and topical minoxidil. Another user suggested using dutasteride for better results.
The conversation discusses the delay in the release of GT20029 for hair loss treatment and skepticism about its effectiveness. Participants mention other treatments like verteporfin and advancements in transplant procedures as more realistic options.
Pyrilutamide is considered by some as an alternative for those avoiding 5AR inhibitors like finasteride and dutasteride, but opinions on its effectiveness vary. Some users report similar results with fluridil and pyrilutamide, while others find pyrilutamide less effective compared to prescription treatments.
The user did not respond to minoxidil and is considering using tretinoin to improve results. They also explored finasteride, microneedling, adapalene, red light therapy, and oral minoxidil as potential treatments.
The conversation is about a user preparing to join the ABS-201 clinical trial for hair loss treatment, which involves a prolactin inhibitor. The user plans to update others on their progress if enrolled.
Low-Level Laser Therapy (LLLT) is seen as a safe and effective method for maintaining hair and promoting regrowth in androgenetic alopecia (AGA) and male pattern baldness (MPB), with devices like the HairMax LaserComb® and iRestore helmet being popular. Some users and professionals are skeptical about its long-term effectiveness and cost.
The user is currently using 0.025% Pantostin but plans to switch to 0.1% Alfatradiol. They will also use high-dose Kx826, high-dose Minoxidil, and aggressive microneedling for hair regrowth.
Exploring hair loss treatments beyond DHT, including Minoxidil, pyruvate, Gt20029 targeting androgen receptors, and vasodilators. Other options like Kx826, adenosine signaling, growth factor topicals, and microneedling are also discussed.
A company is developing a topical dutasteride that targets hair follicles without significantly affecting systemic DHT levels, with trials underway to measure its effectiveness. Users discuss the potential benefits and skepticism around the formulation compared to existing treatments.
The user experienced significant hair regrowth and improved hair volume after 4 months of using oral dutasteride (0.5 mg) and minoxidil (2.5 mg) daily, eliminating the need for a second hair transplant. The user is now satisfied with the results and feels more confident.
The user regained 95% of their hair using dutasteride, oral minoxidil, and doxycycline for skin health, emphasizing patience and consistent treatment. They noted that dutasteride is more effective than finasteride, and maintaining good skin health is crucial for treatment success.
Minoxidil, alfatradiol, nizoral, and pyrilutamide can maintain hair for those who can't tolerate finasteride. Consistent use of these treatments can help prevent further hair loss.
The conversation discusses using topical dutasteride as an alternative to oral finasteride to prevent hair shedding caused by creatine supplementation. Users share experiences with finasteride, dutasteride, and creatine, noting potential side effects and effectiveness concerns with topical treatments.
A user shared their one-year hair treatment results using dutasteride and oral minoxidil, reporting thicker hair without side effects. Others discussed similar treatments, noting improvements in hair thickness and hairline appearance.
Cialis is used to manage erectile dysfunction caused by finasteride and dutasteride, with mixed results. Some users report improvement, while others consider stopping the medication due to side effects.
The user is seeing progress in hair regrowth using a combination of 8% minoxidil, 0.25% dutasteride, and 0.01% tretinoin. The conversation includes comments on the effectiveness and application of these treatments.
Pyrilutamide is discussed as a potential hair loss treatment, acting as an androgen receptor antagonist. The conversation questions if it can maintain hair long-term without using finasteride.
Be cautious when sourcing PP405 or its analogs from third-party suppliers due to potential safety risks and lack of regulatory approval. The conversation highlights concerns about counterfeit products and the absence of reliable testing, making it risky to use such treatments.
Chime Biologics and Hope Medicine are speeding up the launch of a first-in-class antibody drug, HMI-115, for endometriosis and androgenic alopecia. The treatment involves a series of subcutaneous injections, has shown promising results in phase 1, and continues to promote hair regrowth even after the treatment is stopped.
An arthritis drug restored significant hair in people with alopecia areata, but it is not effective for male pattern baldness. The drug, Upadacitinib, has serious side effects and is expensive.
Dutasteride has been effective for long-term hair maintenance, with some users adding oral minoxidil for regrowth. Users discuss experiences with hair transplants, side effects, and other treatments like finasteride and topical solutions.
The user initially used dutasteride, minoxidil, and vitamins, then switched to finasteride but experienced side effects and hair loss. They found better results with a natural supplement containing stinging nettle and beta-sitosterol, reporting thicker hair without side effects.
An 18-year-old is using 0.5 mg dutasteride daily and 5 mg oral minoxidil for hair loss, noticing progress without side effects after three months. They plan to continue treatment for a year before considering other options like a transplant.
Topical dutasteride 0.05% is reported to outperform oral finasteride with minimal side effects, but concerns about study bias exist due to company funding. Some users report mixed results with topical dutasteride, noting issues with skin penetration and systemic absorption.
Amazon now limits medication orders, causing issues for those needing early refills, like the user taking dutasteride. The user is concerned about running out of medication due to these restrictions.
The conversation discusses skepticism about a user's hair restoration progress, with accusations of the post being fake and promoting an AI app. Treatments mentioned include dutasteride and oral minoxidil, with some users discussing side effects and safety of minoxidil.
The conversation is about choosing a topical antiandrogen for hair loss, with options including RU58841, CB0301, Pyrolutamide, Alfatradiol, and Fluridil. Users discuss their preferences and reasons for selecting specific treatments.
A 25-year-old shared their 4-month hair growth progress using minoxidil, dutasteride, and microneedling, claiming no side effects. Some users doubted the rapid transformation, while others praised the results.
The user experienced significant hair regrowth and improved appearance using dutasteride, with no side effects, and is concerned about whether gym workouts and creatine might affect these gains. They previously used minoxidil but disliked its effects and stopped due to its inconvenience.